A290650 Stock Overview
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
L&C BIO Co.,LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,700.00 |
| 52 Week High | ₩34,750.00 |
| 52 Week Low | ₩15,000.00 |
| Beta | 0.42 |
| 11 Month Change | -9.88% |
| 3 Month Change | -11.69% |
| 1 Year Change | -51.17% |
| 33 Year Change | -46.56% |
| 5 Year Change | 133.02% |
| Change since IPO | 85.90% |
Recent News & Updates
Is L&C BIOLTD (KOSDAQ:290650) A Risky Investment?
Nov 12
Here's Why L&C BIOLTD (KOSDAQ:290650) Has A Meaningful Debt Burden
Aug 06What L&C BIO Co.,LTD's (KOSDAQ:290650) 27% Share Price Gain Is Not Telling You
Jul 05L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions
Mar 27Recent updates
Is L&C BIOLTD (KOSDAQ:290650) A Risky Investment?
Nov 12Here's Why L&C BIOLTD (KOSDAQ:290650) Has A Meaningful Debt Burden
Aug 06What L&C BIO Co.,LTD's (KOSDAQ:290650) 27% Share Price Gain Is Not Telling You
Jul 05L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions
Mar 27Does L&C Bio (KOSDAQ:290650) Deserve A Spot On Your Watchlist?
Apr 20L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality
Apr 01Is L&C Bio (KOSDAQ:290650) A Risky Investment?
Mar 02Announcing: L&C Bio (KOSDAQ:290650) Stock Increased An Energizing 163% In The Last Year
Feb 03What Is The Ownership Structure Like For L&C Bio Co., Ltd (KOSDAQ:290650)?
Jan 04Should You Be Excited About L&C Bio Co., Ltd's (KOSDAQ:290650) 16% Return On Equity?
Dec 08Shareholder Returns
| A290650 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 3.5% | -3.5% | 2.5% |
| 1Y | -51.2% | 24.9% | -1.1% |
Return vs Industry: A290650 underperformed the KR Biotechs industry which returned 24.9% over the past year.
Return vs Market: A290650 underperformed the KR Market which returned -1.1% over the past year.
Price Volatility
| A290650 volatility | |
|---|---|
| A290650 Average Weekly Movement | 5.4% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A290650 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A290650's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 124 | Chul Lee Whan | www.lncbio.co.kr |
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
L&C BIO Co.,LTD Fundamentals Summary
| A290650 fundamental statistics | |
|---|---|
| Market cap | ₩378.84b |
| Earnings (TTM) | ₩49.01b |
| Revenue (TTM) | ₩72.04b |
7.7x
P/E Ratio5.3x
P/S RatioIs A290650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A290650 income statement (TTM) | |
|---|---|
| Revenue | ₩72.04b |
| Cost of Revenue | ₩35.38b |
| Gross Profit | ₩36.66b |
| Other Expenses | -₩12.34b |
| Earnings | ₩49.01b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.16k |
| Gross Margin | 50.89% |
| Net Profit Margin | 68.03% |
| Debt/Equity Ratio | 51.5% |
How did A290650 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield5%
Payout RatioDoes A290650 pay a reliable dividends?
See A290650 dividend history and benchmarks| L&C BIOLTD dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 14 2025 |
| Days until Ex dividend | 30 days |
| Days until Dividend pay date | 138 days |
Does A290650 pay a reliable dividends?
See A290650 dividend history and benchmarks